IAG Cargo has expanded its Constant Climate global network that serves the temperature-sensitive pharmaceutical, bioscience and healthcare industry, adding Cincinnati as an approved station.
Cincinnati’s strategic location serves as an ideal station, facilitating freight forwarders throughout the United States in transporting an array of healthcare items from vaccines to clinical trial medicines. This brings the total number of approved Constant Climate stations in the United States to 21.
This newly established station will facilitate the movement of pharmaceuticals that require precise time and temperature management between Cincinnati and London Heathrow. It will leverage IAG Cargo’s extensive network which links six continents to transport critical cargo such as vaccines, medicinal drugs and clinical trial medication around the world. This service will be of special interest to pharmaceutical customers located in Ireland and India whose life-saving medicines frequently transit through London-Heathrow to the United States.
IAG Cargo’s Constant Climate product is a state-of-the-art cold chain solution that caters specifically to the transportation of pharmaceuticals, such as vaccines, biotech products, diagnostics samples, or any other temperature-sensitive pharmaceutical material. During the first half of 2023, Constant Climate, IAG Cargo’s cold chain product for transporting pharmaceutical products, experienced a 45 per cent increase in the volume of pharmaceuticals transported across its network compared to the previous year.
IAG Cargo’s new 10,000m2 facility New Premia at London Heathrow, launched in May 2023, features a cutting-edge Constant Climate Quality Centre (CCQC) for pharmaceuticals, with 27 dedicated cool cells and temperature facilities available from +2°C to +8°C (COL), +15°C to +25°C (CRT) and -20°C (FRO), ensuring sensitive shipments are held in a temperature-controlled environment at all times, highlighted a release.